MCID: STS008
MIFTS: 50

Sotos Syndrome 1 malady

Genetic diseases, Rare diseases, Eye diseases, Fetal diseases, Cancer diseases categories

Aliases & Classifications for Sotos Syndrome 1

About this section
Sources:
49OMIM, 11diseasecard, 22GeneTests, 67UniProtKB/Swiss-Prot, 10Disease Ontology, 21GeneReviews, 45NIH Rare Diseases, 23Genetics Home Reference, 46NINDS, 47Novoseek, 12DISEASES, 51Orphanet, 36MeSH, 24GTR, 65UMLS, 42NCIt, 59SNOMED-CT, 66UMLS via Orphanet, 28ICD10 via Orphanet, 37MESH via Orphanet, 34MedGen
See all sources

Aliases & Descriptions for Sotos Syndrome 1:

Name: Sotos Syndrome 1 49 11 22 67
Sotos Syndrome 10 21 45 23 46 47 12 51 36 67
Cerebral Gigantism 10 21 45 22 23 46 51 67
Sotos' Syndrome 23 24 65
 
Distinctive Facial Appearance, Overgrowth in Childhood, and Learning Disabilities or Delayed Development 45
Chromosome 5q35 Deletion Syndrome 67
Sotos Sequence 23
Sotos1 67


Classifications:



Characteristics (Orphanet epidemiological data):

51
sotos syndrome:
Inheritance: Autosomal dominant,Not applicable; Prevalence: 1-9/1000000 (Europe); Age of onset: Neonatal; Age of death: normal life expectancy


External Ids:

OMIM49 117550
Disease Ontology10 DOID:14748
MeSH36 D058495
NCIt42 C75019
Orphanet51 821
SNOMED-CT59 75968004
UMLS via Orphanet66 C0175695
ICD10 via Orphanet28 Q87.3
MESH via Orphanet37 D058495
MedGen34 C0175695

Summaries for Sotos Syndrome 1

About this section
NIH Rare Diseases:45 Sotos syndrome is a condition characterized mainly by distinctive facial features; overgrowth in childhood; and learning disabilities or delayed development. facial features may include a long, narrow face; a high forehead; flushed (reddened) cheeks; a small, pointed chin; and down-slanting palpebral fissures. affected infants and children tend to grow quickly; they are significantly taller than their siblings and peers and have a large head. other signs and symptoms may include intellectual disability; behavioral problems; problems with speech and language; and/or weak muscle tone (hypotonia). sotos syndrome is usually caused by a mutation in the nsd1 gene and is inherited in an autosomal dominant manner. about 95% of cases are due to a new mutation in the affected person and occur sporadically (are not inherited). last updated: 5/27/2015

MalaCards based summary: Sotos Syndrome 1, also known as sotos syndrome, is related to gigantism and cerebritis, and has symptoms including tall stature, macrocephaly and mandibular prognathia. An important gene associated with Sotos Syndrome 1 is NSD1 (Nuclear Receptor Binding SET Domain Protein 1), and among its related pathways is Lysine degradation. Affiliated tissues include bone, eye and testes, and related mouse phenotype growth/size/body.

Disease Ontology:10 An autosomal recessive disease that occurs rarely and is characterized by excessive physical growth during the first 2 to 3 years of life.

Genetics Home Reference:23 Sotos syndrome is a disorder characterized by a distinctive facial appearance, overgrowth in childhood, and learning disabilities or delayed development of mental and movement abilities. Characteristic facial features include a long, narrow face; a high forehead; flushed (reddened) cheeks; and a small, pointed chin. In addition, the outside corners of the eyes may point downward (down-slanting palpebral fissures). This facial appearance is most notable in early childhood. Affected infants and children tend to grow quickly; they are significantly taller than their siblings and peers and have an unusually large head. However, adult height is usually in the normal range.

NINDS:46 Sotos syndrome (cerebral gigantism) is a rare genetic disorder caused by mutation in the NSD1 gene on chromosome 5.

UniProtKB/Swiss-Prot:67 Sotos syndrome 1: A childhood overgrowth syndrome characterized by pre- and postnatal overgrowth, developmental delay, mental retardation, advanced bone age, and abnormal craniofacial morphology including macrodolichocephaly with frontal bossing, frontoparietal sparseness of hair, apparent hypertelorism, downslanting palpebral fissures, and facial flushing. Common oral findings include: premature eruption of teeth; high, arched palate; pointed chin and, more rarely, prognathism.

Description from OMIM:49 117550

GeneReviews summary for sotos

Related Diseases for Sotos Syndrome 1

About this section

Graphical network of the top 20 diseases related to Sotos Syndrome 1:



Diseases related to sotos syndrome 1

Symptoms for Sotos Syndrome 1

About this section

Symptoms by clinical synopsis from OMIM:

117550

Clinical features from OMIM:

117550

Symptoms:

 51 (show all 47)
  • macrocephaly/macrocrania/megalocephaly/megacephaly
  • frontal bossing/prominent forehead
  • high forehead
  • hypertelorism
  • downslanted palpebral fissures/anti-mongoloid slanting palpebral fissures
  • prognathism/prognathia
  • flattened nose
  • high vaulted/narrow palate
  • long/large ear
  • hypotonia
  • intellectual deficit/mental/psychomotor retardation/learning disability
  • advanced bone age
  • autosomal dominant inheritance
  • tall stature/gigantism/growth acceleration
  • failure to thrive/difficulties for feeding in infancy/growth delay
  • dolichocephaly/scaphocephaly
  • anteverted nares/nostrils
  • premature eruption of teeth/natal teeth
  • conductive deafness/hearing loss
  • hypoglycemia
  • precocious puberty
  • dilated cerebral ventricles without hydrocephaly
  • corpus callosum/septum pellucidum total/partial agenesis
  • immunodeficiency/increased susceptibility to infections/recurrent infections
  • generalized obesity
  • craniostenosis/craniosynostosis/sutural synostosis
  • coarse face
  • micrognathia/retrognathia/micrognathism/retrognathism
  • strabismus/squint
  • scoliosis
  • sacrococcygeal teratoma
  • genu valgum
  • genu varum
  • abnormal fingernails
  • cardiac septal defect
  • patent ductus arteriosus
  • polycystic kidneys
  • ureter/calyx/pelvis duplication/bifid/retrocava/retroiliac ureter
  • hypospadias/epispadias/bent penis
  • undescended/ectopic testes/cryptorchidia/unfixed testes
  • eeg anomalies
  • hypereflexia
  • seizures/epilepsy/absences/spasms/status epilepticus
  • psychic/behavioural troubles
  • hip dislocation/dysplasia/coxa valga/coxa vara/coxa plana
  • neoplasms/tumors
  • central nervous system/peripheral nerves neoplasm/tumor/carcinoma/cancer

HPO human phenotypes related to Sotos Syndrome 1:

(show all 82)
id Description Frequency HPO Source Accession
1 tall stature hallmark (90%) HP:0000098
2 macrocephaly hallmark (90%) HP:0000256
3 mandibular prognathia hallmark (90%) HP:0000303
4 hypertelorism hallmark (90%) HP:0000316
5 high forehead hallmark (90%) HP:0000348
6 macrotia hallmark (90%) HP:0000400
7 depressed nasal ridge hallmark (90%) HP:0000457
8 downslanted palpebral fissures hallmark (90%) HP:0000494
9 frontal bossing hallmark (90%) HP:0002007
10 accelerated skeletal maturation hallmark (90%) HP:0005616
11 cognitive impairment hallmark (90%) HP:0100543
12 dolichocephaly typical (50%) HP:0000268
13 conductive hearing impairment typical (50%) HP:0000405
14 anteverted nares typical (50%) HP:0000463
15 precocious puberty typical (50%) HP:0000826
16 obesity typical (50%) HP:0001513
17 hypoglycemia typical (50%) HP:0001943
18 advanced eruption of teeth typical (50%) HP:0006288
19 abnormality of immune system physiology typical (50%) HP:0010978
20 cryptorchidism occasional (7.5%) HP:0000028
21 abnormality of the ureter occasional (7.5%) HP:0000069
22 polycystic kidney dysplasia occasional (7.5%) HP:0000113
23 coarse facial features occasional (7.5%) HP:0000280
24 micrognathia occasional (7.5%) HP:0000347
25 strabismus occasional (7.5%) HP:0000486
26 behavioral abnormality occasional (7.5%) HP:0000708
27 abnormality of the fingernails occasional (7.5%) HP:0001231
28 seizures occasional (7.5%) HP:0001250
29 hyperreflexia occasional (7.5%) HP:0001347
30 craniosynostosis occasional (7.5%) HP:0001363
31 patent ductus arteriosus occasional (7.5%) HP:0001643
32 eeg abnormality occasional (7.5%) HP:0002353
33 scoliosis occasional (7.5%) HP:0002650
34 genu valgum occasional (7.5%) HP:0002857
35 genu varum occasional (7.5%) HP:0002970
36 abnormality of the hip bone occasional (7.5%) HP:0003272
37 neoplasm of the nervous system occasional (7.5%) HP:0004375
38 presacral teratoma occasional (7.5%) HP:0009793
39 displacement of the external urethral meatus occasional (7.5%) HP:0100627
40 tall stature HP:0000098
41 macrocephaly HP:0000256
42 mandibular prognathia HP:0000303
43 intellectual disability HP:0001249
44 accelerated skeletal maturation HP:0005616
45 autosomal dominant inheritance HP:0000006
46 narrow palate HP:0000189
47 high palate HP:0000218
48 dolichocephaly HP:0000268
49 pointed chin HP:0000307
50 hypertelorism HP:0000316
51 otitis media HP:0000388
52 conductive hearing impairment HP:0000405
53 strabismus HP:0000486
54 downslanted palpebral fissures HP:0000494
55 hypermetropia HP:0000540
56 nystagmus HP:0000639
57 behavioral abnormality HP:0000708
58 large hands HP:0001176
59 seizures HP:0001250
60 global developmental delay HP:0001263
61 neonatal hypotonia HP:0001319
62 partial agenesis of the corpus callosum HP:0001338
63 hyperreflexia HP:0001347
64 joint laxity HP:0001388
65 ventricular septal defect HP:0001629
66 atria septal defect HP:0001631
67 patent ductus arteriosus HP:0001643
68 pes planus HP:0001763
69 small nail HP:0001792
70 long foot HP:0001833
71 abnormal glucose tolerance HP:0001952
72 frontal bossing HP:0002007
73 enlarged cisterna magna HP:0002280
74 poor coordination HP:0002370
75 cavum septum pellucidum HP:0002389
76 expressive language delay HP:0002474
77 scoliosis HP:0002650
78 nephroblastoma (wilms tumor) HP:0002667
79 genu valgum HP:0002857
80 sporadic HP:0003745
81 advanced eruption of teeth HP:0006288
82 high anterior hairline HP:0009890

Drugs & Therapeutics for Sotos Syndrome 1

About this section

Drugs for Sotos Syndrome 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 6)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
ZidovudineapprovedPhase 448930516-87-135370
Synonyms:
-Azido-3&prime
-deoxythymidine
1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine
3&prime
3' Azido 2',3' Dideoxythymidine
3' Azido 3' deoxythymidine
3'-Azido-2',3'-Dideoxythymidine
3'-Azido-3'-deoxythymidine
3'-Azido-3'-deoxythymidine & Concanavalin A
3'-Azido-3'-deoxythymidine & Erythropoietin
3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19
3'-Azido-3'-deoxythymidine & Interleukin-1
3'-Azido-3'-deoxythymidine & Interleukin-2
3'-Azido-3'-deoxythymidine & Interleukin-6
3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6
3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon
3'-Azido-3'-deoxythymidine & Sho-Saiko-To
3'-Azido-3'-deoxythymidine (AIDS)
3'-Azido-3'deoxythymidine & Interferon .alpha.
3'-Azidothymidine
3'-Deoxy-3'-azidothymidine
3'-azido-3'-deoxythymidine, AZT
3-Azido-3-deoxythymidine
30516-87-1
399024-19-2
A2169_SIGMA
AC1L1TKL
AC1Q2OEK
AZT
AZT & CD4(178)-PE 40
AZT & Colony-stimulating factor 2
AZT & Concanavalin A (ConA)
AZT & EPO
AZT & GM-CSF
AZT & HPA
AZT & IFN.alpha.
AZT & IL-1
AZT & IL-2
AZT & IL-6
AZT & Interferon-.alpha.-2
AZT & Li & EPO
AZT & Li & GM-CSF
AZT & Li & IL-1
AZT & Li & IL-6
AZT & Lymphoblastoid Interferon
AZT & NP (from PHCA or HSA)
AZT & PM-19
AZT & SST
AZT & rIFN.alpha.2
AZT & rsCD4 & rIFN.alpha.A
AZT & rsT4
AZT & sCD4
AZT & srCD4
AZT (Antiviral)
AZT Antiviral
AZT TRANSPLACENTAL CARCINOGENESIS STUDY
AZT+PRO 140
AZT, Antiviral
Antiviral AZT
Apo-Zidovudine
Azidothymidine
Aztec
BB_NC-1012
BPBio1_000403
BRD-K72903603-001-04-6
BSPBio_000365
BSPBio_003153
BW A509U
BW-A 509U
BW-A-509U
BW-A509U
BWA 509U
BWA-509U
BWA509U
C07210
CCRIS 105
CHEBI:10110
CHEBI:127307
CHEMBL129
CID35370
CPD000058351
 
Compound S
Cpd S
D00413
D015215
DB00495
DRG-0004
DS-4152 & AZT
DivK1c_000524
HMS1921J20
HMS2090G11
HMS2092D06
HMS501K06
HSDB 6515
IDI1_000524
Interferon AD + 3'-azido-3'-deoxythymidine
Intron A & AZT
K7 [P Ti2 W10 O40]
KBio1_000524
KBio2_001828
KBio2_004396
KBio2_006964
KBio3_002653
KBioGR_000703
KBioSS_001828
LS-1159
Liposomal AZT-SN-1
Liposomal AZT-SN-3
MLS000028548
MLS001055351
MLS001076358
MLS002153202
MLS002222249
Met-SDF-1.beta. & AZT
Met-SDF-1.beta. & Zidovudine
MolPort-002-507-286
NCGC00023945-03
NCGC00023945-04
NCGC00023945-05
NCGC00023945-08
NCGC00178237-01
NCGC00178237-02
NINDS_000524
NSC 602670
Novo-Azt
PC-SOD+AZT
Prestwick3_000333
Propolis+AZT
Racemic Liposomal AZT
Retrovir
Retrovir (TN)
Retrovir(TM)
SAM002548971
SMR000058351
SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SPBio_000834
SPECTRUM1502109
STK801891
Spectrum2_000927
Spectrum3_001507
Spectrum4_000332
Spectrum5_001101
Spectrum_001348
UNII-4B9XT59T7S
ZDV
ZIDOVUDINE [AZT]
ZINC03779042
ZVD
Zidovudin
Zidovudina
Zidovudina [Spanish]
Zidovudine
Zidovudine (JAN/USP/INN)
Zidovudine EP III
Zidovudine [USAN:INN:BAN:JAN]
Zidovudine+PRO 140
Zidovudinum
Zidovudinum [Latin]
antiviral
azidodeoxythymidine
rIFN-beta seron & AZT
racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
zidovudin
zidovudine
2
AspirinapprovedPhase 497150-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
7 Select Adult Chewable Aspirin
7 Select Aspirin
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Adult Chewable Low Dose Aspirin
Adult Low Dose Aspirin
Adult Low Dose Aspirin Enteric Safety Coated
Adult Low Dose Enteric Coated Aspirin
Adult Low Strength Aspirin
Aloxiprimum
Asacard
Asagran
Asaphen
Asatard
Ascoden-30
Ascriptin Maximum Strength Buffered Aspirin
Ascriptin Regular Strength Buffered Aspirin
Aspalon
Aspec
Aspergum
Aspi-cor
Aspir Low
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin 81 Mg
Aspirin 81 Mg Low Dose
Aspirin Adult Low Dose
Aspirin Adult Low Strength
Aspirin Adult Low Strength Aspirin
Aspirin Adult low strength
Aspirin Chewable Low Dose
Aspirin Delayed Release
Aspirin EC
Aspirin EXTRA STRENGTH
Aspirin Ec
Aspirin Enteric
Aspirin Enteric Coated
Aspirin Enteric Coated Low Dose
Aspirin Enteric Safety Coated
Aspirin Enteric Safety-Coated
Aspirin Low Dose
Aspirin Low Dose Chewable
Aspirin Low Dose Enteric Coated
Aspirin Low Dose Safety Coated
Aspirin Low Strength
Aspirin Nsaid
Aspirin Regular Strength
Aspirin Regular Strength regular strength
Aspirin Regular strength
Aspirin Safety Coated
Aspirin Safety Coated Adult Low Dose
Aspirin Safety coated
Aspirin Thin coated
Aspirin [BAN:JAN]
Aspirin adult low dose
Aspirin adult low strength
Aspirin enteric safety coated
Aspirin low dose
Aspirin low dose chewable
Aspirin low dose enteric coated
Aspirin regular strength
Aspirina 03
Aspirine
Aspiring
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Advanced Aspirin Extra Strength
Bayer Advanced Aspirin Regular Strength
Bayer Aspirin 8 Hour
Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange
Bayer Aspirin Regimen Regular Strength
Bayer Buffered
Bayer Chewable - Aspirin Regimen Low Dose Aspirin Cherry Flavored
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Fast Release
Bayer Genuine Aspirin
Bayer Low Dose
Bayer Plus
Bayer Plus Extra Strength
Bayer Womens
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Buffered Aspirin
Bufferin
Bufferin LOW DOSE BUFFERED ASPIRIN
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Care One Aspirin
Cemirit
Chewable Adult Low Dose Aspirin
Chewable Aspirin
Chewable Low Dose Aspirin
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Critical Care Aspirin To Go
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dg Health Aspirin
Direct Safety Aspirin
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ec-81aspirin Enteric Coated
Ecolen
Ecotrin
Ecotrin Regular Strength
Empirin
Empirin with Codeine
Endosprin
Endydol
Enteric Aspirin
Enteric Coated Aspirin
Enteric Coated Aspirin Regular Strength
Enteric Coated Aspirin Regular strength
Enteric Coated Aspirin regular strength
Enteric Coated Asprin 81 Mg
Enteric Coated Low Dose Aspirin
 
Enteric Safety Coated Aspirin
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Equaline Aspirin
Equaline Aspirin adult low dose
Equate Aspirin
Equate Aspirin chewable
Extren
Fasprin
Flanax Aspirin Pain Reliever
Formucare Aspirin
Genuine Aspirin
Globentyl
Globoid
Good Neighbor Pharmacy Aspirin
Good Neighbor Pharmacy Aspirin Enteric Safety Coated
Good Neighbor Pharmacy Aspirin orange flavor chewable
Good Sense Aspirin
Good Sense Aspirin Enteric Safety Coated
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Handy Solutions Genuine Aspirin Bayer
Health Mart Aspirin
Health Mart Regular Strength Enteric Coated Aspirin
Health Sense Adult Chewable Low Strength Aspirin
Health Sense Aspirin 81
Health Sense Ecpirin
Healthy Accents Aspirin
Helicon
Henry Schein Aspirin
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kroger Value Aspirin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Leader Aspirin
Leader Cardinal Health Aspirin
Leader Low Dose Aspirin
Levius
Lopac-A-5376
Lopac0_000038
Low Dose Adult Aspirin
Low Dose Aspirin
Low Dose Aspirin 81 Mg Safety Coated
Low Dose Aspirin Enteric Safety Coated
Low Dose Asprin
Low Dose Chewable Aspirin
Low Dose Miniprin Enteric Safety Coated
Low Dose Pain Relief Aspirin
Low Strength Chewable Aspirin
Low-dose Aspirin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medi First Plus Aspirin
Medi-first Aspirin
Medique Aspirin
Medisyl
Micristin
Micro-coated Aspirin
Miniprin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
North Aspirin
Novasen
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Pain Relief Aspirin
Pain Relief Aspirin Low Dose
Persistin
Pharbest Aspirin 325mg
Pharbest Regular Strength Aspirin
Pharmacin
Pirseal
Plus Pharma NSAID 325 mg
Plus Pharma Nsaid Aspirin
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rapid Comfort Aspirin
Regular Strength Aspirin
Regular Strength Aspirin Ec
Regular Strength Buffered Aspirin
Regular Strength Enteric Aspirin
Regular Strength Enteric Coated Aspirin
Regular Strength Pain Relief
Regular Strength Tri-buffered Aspirin
Rexall Aspirin
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
Rugby Aspirin
Rx Act Aspirin
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Safety Coated Aspirin
Safety Coated Enteric Aspirin
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Smart Health Aspirin regular strength
Smart Sense Aspirin
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Solves - Aspirin Cherry
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
St. Joseph Chewable Aspirin
St. Joseph Safety Coated Aspirin
Sunmark Aspirin
Sunmark Aspirin Regular Strength
Sunmark Aspirin adult low strength
Sunmark Aspirin low dose
Supac
Tasprin
Temperal
Toldex
Topcare Aspirin
Tri-buffered Aspirin
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Uncoated Aspirin
Value Pharma Aspirin Pain Reliever
Value Pharmapain Reliever Extra Strength
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
Zee Aspirin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
3
Ritonavirapproved, investigationalPhase 4833155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir
4
LopinavirapprovedPhase 4338192725-17-092727
Synonyms:
(1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
(alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide
1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI)
192725-17-0
1mui
2o4s
2q5k
2rkf
2rkg
A 157378
A 157378.0
A-157378-0
A-157378.0
AB1
ABT 157378
ABT 378
ABT-378
ABT-378, LOPINAVIR
AC1L3OPJ
AIDS032937
Aluviran
C12871
C37H48N4O5
 
CHEBI:40456
CHEMBL729
CID92727
D01425
DB01601
Kaletra
Koletra
LPV
LS-173766
Lopinavir
Lopinavir (JAN/USAN/INN)
Lopinavir [USAN:INN:BAN]
MolPort-003-848-410
N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE
NCGC00164576-01
NCGC00164576-02
RS-346
S1380_Selleck
SID124893167
SID144205757
SID50111692
UNII-2494G1JF75
a-157378-0
a-157378.0
5
Lamivudineapproved, investigationalPhase 4575134678-17-460825
Synonyms:
(+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(+/-)-3TC
(+/-)-BCH-189
(+/-)-SddC
(-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-2'-Deoxy-3'-thiacytidine
(-)-BCH 189
(-)-BCH-189
(-)-SddC
(-)-beta-L-2',3'-Dideoxy-3'-thiacytidine
(-)NGPB-21
(2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
.beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To
134678-17-4
2',3' Dideoxy 3' thiacytidine
2',3'-Dideoxy-3'-thiacytidine
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA)
3'-Thia-2',3'-dideoxycytidine
3-TC
3TC
3TC & GNA
3TC & SST
3TC (AIDS INITIATIVE) (AIDS INITIATIVE)
3TC and NV-01
3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine
4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
480434-79-5
AC-1416
AC1L1TZZ
AC1Q6C34
BCH 189
BCH-189
BCH-790
BCH189
BIDD:GT0033
Bio-0652
C07065
C8H11N3O3S
CCRIS 9274
CHEBI:133986
CHEMBL141
CID60825
CPD000466319
D00353
D019259
DB00709
 
DRG-0126
DTHC
Epivir
Epivir (TN)
Epivir HBV
Epivir(TM)
Epivir-HBV
Epzicom
FT-0082667
GG-714
GR 109714 X
GR 109714X
GR-109714X
GR109714X
HHA & 3TC
HHA & Lamivudine
HMS2051D21
HSDB 7155
Hepitec
Heptivir
Heptodin
Heptovir
L0217
LMV
LS-2107
Lamivir
Lamivudin
Lamivudina
Lamivudine
Lamivudine & GNA
Lamivudine (JAN/USP/INN)
Lamivudine [USAN:BAN:INN]
Lamivudine [USAN:INN:BAN]
Lamivudine [Usan:Ban:Inn]
Lamivudine, (2S-cis)-Isomer
Lamivudinum
MLS000759424
MLS001424097
MolPort-002-507-347
NCGC00159341-03
NCGC00159341-04
NSC620753
S1706_Selleck
SAM001246582
SAM002589994
SMR000466319
STK801940
UNII-2T8Q726O95
ZINC00012346
Zeffix
Zefix
beta-L-2',3'-Dideoxy-3'-thiacytidine
beta-L-3'-Thia-2',3'-dideoxycytidine
lamivudine
6
Efavirenzapproved, investigationalPhase 4390154598-52-464139
Synonyms:
(-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(-)-Efavirenz
(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben
(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-chloro-4-Cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one
154598-52-4
1ikv
1ikw
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- (9
6-chloro-4-(2-Cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one
6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
AC-19049
AC1L20IX
BIDD:GT0383
C08088
C14H9ClF3NO2
CHEBI:119486
CHEMBL223228
CID64139
CPD000466351
D00896
DB00625
DB07709
DMP 266
DMP-266
EFV
 
EFZ
Efavirenz
Efavirenz (JAN/INN)
Efavirenzum
Eravirenz
HMS2051J08
HMS2090N16
HSDB 7163
L 743726
L-741211
L-743,726
L-743725
L-743726
LS-173464
MLS000759465
MLS001424087
Met-SDF-1.beta. & Efavirenz
Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz
MolPort-003-983-924
NSC742403
SAM001246667
SBB066062
SMR000466351
Stocrin
Strocin (TM)
Sustiva
Sustiva (TM)
Sustiva (TN)
UNII-JE6H2O27P8
ZINC02020233
efavirenz
efavirenz, (S)-isomer
zoxazin-2-one
Éfavirenz

Interventional clinical trials:

idNameStatusNCT IDPhase
1PI Vs. NNRTI Based Therapy for HIV Advanced DiseaseRecruitingNCT00162643Phase 4
2Chronotherapy With Low-dose Aspirin for Primary PreventionRecruitingNCT00725127Phase 4
3A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.CompletedNCT00616798Phase 2
4Third International Study on Mechanical VentilationCompletedNCT01093482

Search NIH Clinical Center for Sotos Syndrome 1


Cochrane evidence based reviews: Sotos Syndrome

Genetic Tests for Sotos Syndrome 1

About this section

Genetic tests related to Sotos Syndrome 1:

id Genetic test Affiliating Genes
1 Sotos Syndrome 122 NSD1
2 Sotos' Syndrome24

Anatomical Context for Sotos Syndrome 1

About this section

MalaCards organs/tissues related to Sotos Syndrome 1:

33
Bone, Eye, Testes, Kidney

Animal Models for Sotos Syndrome 1 or affiliated genes

About this section

MGI Mouse Phenotypes related to Sotos Syndrome 1:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053787.6APC2, DPH1, GPC3, IGFBP3, NFIX, SETD2

Publications for Sotos Syndrome 1

About this section

Articles related to Sotos Syndrome 1:

idTitleAuthorsYear
1
Sotos syndrome 1 and 2. (25345081)
2014

Variations for Sotos Syndrome 1

About this section

UniProtKB/Swiss-Prot genetic disease variations for Sotos Syndrome 1:

67 (show all 14)
id Symbol AA change Variation ID SNP ID
1NSD1p.His1616LeuVAR_015780
2NSD1p.Leu1637ProVAR_015781
3NSD1p.Cys1674TrpVAR_015782
4NSD1p.Ile1687AsnVAR_015783
5NSD1p.Gly1792ValVAR_015784
6NSD1p.Cys1925ArgVAR_015785
7NSD1p.Gly1955AspVAR_015786
8NSD1p.Arg1984GlnVAR_015787
9NSD1p.Tyr1997CysVAR_015788
10NSD1p.Arg2005GlnVAR_015789
11NSD1p.Arg2017GlnVAR_015790
12NSD1p.Arg2017TrpVAR_015791
13NSD1p.His2143GlnVAR_015792
14NSD1p.Cys2183SerVAR_015793

Clinvar genetic disease variations for Sotos Syndrome 1:

5 (show all 185)
id Gene Variation Type Significance SNP ID Assembly Location
1NSD1NM_022455.4(NSD1): c.1077delG (p.Arg359Serfs)deletionPathogenicrs587784068GRCh37Chr 5, 176631134: 176631134
2NSD1NM_022455.4(NSD1): c.1262G> A (p.Trp421Ter)single nucleotide variantPathogenicrs587784071GRCh37Chr 5, 176636662: 176636662
3NSD1NM_022455.4(NSD1): c.1456delT (p.Ser486Leufs)deletionPathogenicrs587784073GRCh37Chr 5, 176636856: 176636856
4NSD1NM_022455.4(NSD1): c.1810C> T (p.Arg604Ter)single nucleotide variantPathogenicrs587784076GRCh38Chr 5, 177210209: 177210209
5NSD1NM_022455.4(NSD1): c.1831C> T (p.Arg611Ter)single nucleotide variantPathogenicrs587784077GRCh37Chr 5, 176637231: 176637231
6NSD1NM_022455.4(NSD1): c.2014_2018delACAGA (p.Thr672Glufs)deletionPathogenicrs587784078GRCh37Chr 5, 176637414: 176637418
7NSD1NM_022455.4(NSD1): c.2048delA (p.Lys683Argfs)deletionPathogenicrs587784079GRCh37Chr 5, 176637448: 176637448
8NSD1NM_022455.4(NSD1): c.2049_2053delGATAA (p.Ile684Valfs)deletionPathogenicrs587784080GRCh37Chr 5, 176637449: 176637453
9NSD1NM_022455.4(NSD1): c.2064delG (p.Arg688Serfs)deletionPathogenicrs587784081GRCh38Chr 5, 177210463: 177210463
10NSD1NM_022455.4(NSD1): c.2124_2127delTACA (p.His708Glnfs)deletionPathogenicrs587784082GRCh37Chr 5, 176637524: 176637527
11NSD1NM_022455.4(NSD1): c.2276C> G (p.Ser759Ter)single nucleotide variantPathogenicrs587784084GRCh37Chr 5, 176637676: 176637676
12NSD1NM_022455.4(NSD1): c.2295delC (p.Ser766Argfs)deletionPathogenicrs587784085GRCh38Chr 5, 177210694: 177210694
13NSD1NM_022455.4(NSD1): c.2339C> A (p.Ser780Ter)single nucleotide variantPathogenicrs201327209GRCh38Chr 5, 177210738: 177210738
14NSD1NM_022455.4(NSD1): c.2386_2389delGAAA (p.Glu796Ilefs)deletionPathogenicrs587784086GRCh38Chr 5, 177210785: 177210788
15NSD1NM_022455.4(NSD1): c.2639delG (p.Gly880Glufs)deletionPathogenicrs587784087GRCh38Chr 5, 177211038: 177211038
16NSD1NM_022455.4(NSD1): c.2654C> A (p.Ser885Ter)single nucleotide variantPathogenicrs587784088GRCh38Chr 5, 177211053: 177211053
17NSD1NM_022455.4(NSD1): c.2827delG (p.Asp943Thrfs)deletionPathogenicrs587784089GRCh37Chr 5, 176638227: 176638227
18NSD1NM_022455.4(NSD1): c.2954_2955delCT (p.Ser985Cysfs)deletionPathogenicrs587784092GRCh37Chr 5, 176638354: 176638355
19NSD1NM_022455.4(NSD1): c.2956delG (p.Ala986Hisfs)deletionPathogenicrs587784093GRCh37Chr 5, 176638356: 176638356
20NSD1NM_022455.4(NSD1): c.3046_3047delGT (p.Val1016Tyrfs)deletionPathogenicrs587784094GRCh37Chr 5, 176638446: 176638447
21NSD1NM_022455.4(NSD1): c.3067C> T (p.Arg1023Ter)single nucleotide variantPathogenicrs587784095GRCh37Chr 5, 176638467: 176638467
22NSD1NM_022455.4(NSD1): c.3091C> T (p.Arg1031Ter)single nucleotide variantPathogenicrs587784096GRCh37Chr 5, 176638491: 176638491
23NSD1NM_022455.4(NSD1): c.3185_3186delTG (p.Val1062Aspfs)deletionPathogenicrs587784097GRCh38Chr 5, 177211584: 177211585
24NSD1NM_022455.4(NSD1): c.3214C> T (p.Arg1072Ter)single nucleotide variantPathogenicrs587784098GRCh38Chr 5, 177211613: 177211613
25NSD1NM_022455.4(NSD1): c.3293delC (p.Thr1098Lysfs)deletionPathogenicrs587784099GRCh38Chr 5, 177211692: 177211692
26NSD1NM_022455.4(NSD1): c.3295delA (p.Ser1099Valfs)deletionPathogenicrs587784100GRCh37Chr 5, 176638695: 176638695
27NSD1NM_022455.4(NSD1): c.3383_3384delCT (p.Ser1128Phefs)deletionPathogenicrs587784101GRCh37Chr 5, 176638783: 176638784
28NSD1NM_022455.4(NSD1): c.3578_3582delGTGAC (p.Ser1193Thrfs)deletionPathogenicrs587784103GRCh37Chr 5, 176638978: 176638982
29NSD1NM_022455.4(NSD1): c.3659_3660delAG (p.Glu1220Alafs)deletionPathogenicrs587784104GRCh37Chr 5, 176639059: 176639060
30NSD1NM_022455.4(NSD1): c.3839G> A (p.Trp1280Ter)single nucleotide variantPathogenicrs587784105GRCh37Chr 5, 176662864: 176662864
31NSD1NM_022455.4(NSD1): c.3964C> T (p.Arg1322Ter)single nucleotide variantPathogenicrs587784107GRCh37Chr 5, 176665280: 176665280
32NSD1NM_022455.4(NSD1): c.4057G> T (p.Glu1353Ter)single nucleotide variantPathogenicrs587784109GRCh37Chr 5, 176665373: 176665373
33NSD1NM_022455.4(NSD1): c.4076C> G (p.Ser1359Ter)single nucleotide variantPathogenicrs587784110GRCh38Chr 5, 177238391: 177238391
34NSD1NM_022455.4(NSD1): c.4192+2T> Gsingle nucleotide variantPathogenicrs587784111GRCh38Chr 5, 177238509: 177238509
35NSD1NM_022455.4(NSD1): c.4301delA (p.Lys1434Serfs)deletionPathogenicrs587784112GRCh38Chr 5, 177239864: 177239864
36NSD1NM_022455.4(NSD1): c.4376delG (p.Gly1459Glufs)deletionPathogenicrs587784114GRCh37Chr 5, 176671269: 176671269
37NSD1NM_022455.4(NSD1): c.4378+1G> Asingle nucleotide variantPathogenicrs587784115GRCh37Chr 5, 176671272: 176671272
38NSD1NM_022455.4(NSD1): c.4411C> T (p.Arg1471Ter)single nucleotide variantPathogenicrs570278338GRCh37Chr 5, 176673711: 176673711
39NSD1NM_022455.4(NSD1): c.4417C> T (p.Arg1473Ter)single nucleotide variantPathogenicrs587784117GRCh37Chr 5, 176673717: 176673717
40NSD1NM_022455.4(NSD1): c.4444C> T (p.Gln1482Ter)single nucleotide variantPathogenicrs587784118GRCh37Chr 5, 176673744: 176673744
41NSD1NM_022455.4(NSD1): c.4493C> G (p.Ser1498Ter)single nucleotide variantPathogenicrs587784119GRCh37Chr 5, 176673793: 176673793
42NSD1NM_022455.4(NSD1): c.4498-3A> Gsingle nucleotide variantPathogenicrs587784120GRCh37Chr 5, 176675179: 176675179
43NSD1NM_022455.4(NSD1): c.4529delG (p.Ser1510Thrfs)deletionPathogenicrs587784121GRCh37Chr 5, 176675213: 176675213
44NSD1NM_022455.4(NSD1): c.4681C> T (p.Gln1561Ter)single nucleotide variantPathogenicrs587784122GRCh37Chr 5, 176678770: 176678770
45NSD1NM_022455.4(NSD1): c.4705delG (p.Glu1569Serfs)deletionPathogenicrs587784123GRCh37Chr 5, 176678794: 176678794
46NSD1NM_022455.4(NSD1): c.4731_4732delAA (p.Gly1579Lysfs)deletionPathogenicrs587784124GRCh37Chr 5, 176678820: 176678821
47NSD1NM_022455.4(NSD1): c.4745delT (p.Ile1582Thrfs)deletionPathogenicrs587784125GRCh37Chr 5, 176678834: 176678834
48NSD1NM_022455.4(NSD1): c.4753G> T (p.Glu1585Ter)single nucleotide variantPathogenicrs587784126GRCh37Chr 5, 176678842: 176678842
49NSD1NM_022455.4(NSD1): c.4817G> A (p.Cys1606Tyr)single nucleotide variantLikely pathogenicrs587784127GRCh37Chr 5, 176684003: 176684003
50NSD1NM_022455.4(NSD1): c.4844A> C (p.Tyr1615Ser)single nucleotide variantLikely pathogenicrs398124378GRCh37Chr 5, 176684030: 176684030
51NSD1NM_022455.4(NSD1): c.4855T> A (p.Cys1619Ser)single nucleotide variantPathogenicrs587784128GRCh37Chr 5, 176684041: 176684041
52NSD1NM_022455.4(NSD1): c.4855T> G (p.Cys1619Gly)single nucleotide variantPathogenicrs587784128GRCh37Chr 5, 176684041: 176684041
53NSD1NM_022455.4(NSD1): c.4907C> T (p.Ser1636Phe)single nucleotide variantPathogenicrs587784129GRCh37Chr 5, 176684093: 176684093
54NSD1NM_022455.4(NSD1): c.4966+1G> Asingle nucleotide variantPathogenicrs587784131GRCh37Chr 5, 176684153: 176684153
55NSD1NM_022455.4(NSD1): c.4966G> T (p.Gly1656Cys)single nucleotide variantPathogenicrs587784132GRCh37Chr 5, 176684152: 176684152
56NSD1NM_022455.4(NSD1): c.4967-2A> Tsingle nucleotide variantPathogenicrs587784133GRCh37Chr 5, 176686988: 176686988
57NSD1NM_022455.4(NSD1): c.4987C> T (p.Arg1663Cys)single nucleotide variantPathogenicrs587784134GRCh37Chr 5, 176687010: 176687010
58NSD1NM_022455.4(NSD1): c.5021G> A (p.Cys1674Tyr)single nucleotide variantLikely pathogenicrs587784135GRCh37Chr 5, 176687044: 176687044
59NSD1NM_022455.4(NSD1): c.5098C> T (p.Arg1700Ter)single nucleotide variantPathogenicrs587784137GRCh37Chr 5, 176687121: 176687121
60NSD1NM_022455.4(NSD1): c.5141C> G (p.Ser1714Ter)single nucleotide variantPathogenicrs587784138GRCh37Chr 5, 176687164: 176687164
61NSD1NM_022455.4(NSD1): c.5146+1G> Asingle nucleotide variantPathogenicrs587784139GRCh37Chr 5, 176687170: 176687170
62NSD1NM_022455.4(NSD1): c.5198G> A (p.Cys1733Tyr)single nucleotide variantLikely pathogenicrs587784140GRCh37Chr 5, 176694614: 176694614
63NSD1NM_022455.4(NSD1): c.5303+1G> Csingle nucleotide variantPathogenicrs587784141GRCh37Chr 5, 176694720: 176694720
64NSD1NM_022455.4(NSD1): c.5309G> A (p.Trp1770Ter)single nucleotide variantPathogenicrs587784142GRCh37Chr 5, 176696608: 176696608
65NSD1NM_022455.4(NSD1): c.5375G> A (p.Gly1792Glu)single nucleotide variantPathogenicrs587784143GRCh37Chr 5, 176696674: 176696674
66NSD1NM_022455.4(NSD1): c.5390T> C (p.Leu1797Pro)single nucleotide variantLikely pathogenicrs587784144GRCh37Chr 5, 176696689: 176696689
67NSD1NM_022455.4(NSD1): c.5392_5398delTTTTTTG (p.Phe1798Aspfs)deletionPathogenicrs587784145GRCh37Chr 5, 176696691: 176696697
68NSD1NM_022455.4(NSD1): c.5419A> C (p.Thr1807Pro)single nucleotide variantLikely pathogenicrs587784146GRCh37Chr 5, 176696718: 176696718
69NSD1NM_022455.4(NSD1): c.5425C> T (p.Gln1809Ter)single nucleotide variantPathogenicrs587784147GRCh37Chr 5, 176696724: 176696724
70NSD1NM_022455.4(NSD1): c.5431C> T (p.Arg1811Ter)single nucleotide variantPathogenicrs587784148GRCh37Chr 5, 176696730: 176696730
71NSD1NM_022455.4(NSD1): c.5432G> A (p.Arg1811Gln)single nucleotide variantPathogenicrs587784149GRCh37Chr 5, 176696731: 176696731
72NSD1NM_022455.4(NSD1): c.5471A> G (p.Asp1824Gly)single nucleotide variantLikely pathogenicrs587784150GRCh37Chr 5, 176696770: 176696770
73NSD1NM_022455.4(NSD1): c.5566C> T (p.Gln1856Ter)single nucleotide variantPathogenicrs587784151GRCh37Chr 5, 176700729: 176700729
74NSD1NM_022455.4(NSD1): c.5618_5619delTA (p.Ile1873Lysfs)deletionPathogenicrs587784152GRCh37Chr 5, 176700781: 176700782
75NSD1NM_022455.4(NSD1): c.5712delC (p.Cys1905Valfs)deletionPathogenicrs587784153GRCh37Chr 5, 176707655: 176707655
76NSD1NM_022455.4(NSD1): c.5740C> T (p.Arg1914Cys)single nucleotide variantPathogenicrs587784154GRCh37Chr 5, 176707683: 176707683
77NSD1NM_022455.4(NSD1): c.5741G> C (p.Arg1914Pro)single nucleotide variantLikely pathogenicrs587784155GRCh37Chr 5, 176707684: 176707684
78NSD1NM_022455.4(NSD1): c.5798A> G (p.Asn1933Ser)single nucleotide variantLikely pathogenicrs587784156GRCh37Chr 5, 176707741: 176707741
79NSD1NM_022455.4(NSD1): c.5800C> T (p.Gln1934Ter)single nucleotide variantPathogenicrs587784157GRCh37Chr 5, 176707743: 176707743
80NSD1NM_022455.4(NSD1): c.5805C> A (p.Cys1935Ter)single nucleotide variantPathogenicrs587784158GRCh37Chr 5, 176707748: 176707748
81NSD1NM_022455.4(NSD1): c.5862G> C (p.Trp1954Cys)single nucleotide variantPathogenicrs587784160GRCh37Chr 5, 176707805: 176707805
82NSD1NM_022455.4(NSD1): c.5885T> C (p.Ile1962Thr)single nucleotide variantPathogenicrs587784162GRCh37Chr 5, 176707828: 176707828
83NSD1NM_022455.4(NSD1): c.5893-2A> Gsingle nucleotide variantPathogenicrs587784163GRCh37Chr 5, 176709464: 176709464
84NSD1NM_022455.4(NSD1): c.5903delT (p.Val1968Glyfs)deletionPathogenicrs587784164GRCh37Chr 5, 176709476: 176709476
85NSD1NM_022455.4(NSD1): c.5911delT (p.Tyr1971Metfs)deletionPathogenicrs587784165GRCh37Chr 5, 176709484: 176709484
86NSD1NM_022455.4(NSD1): c.5918G> T (p.Gly1973Val)single nucleotide variantLikely pathogenicrs587784166GRCh37Chr 5, 176709491: 176709491
87NSD1NM_022455.4(NSD1): c.5927T> A (p.Ile1976Lys)single nucleotide variantLikely pathogenicrs587784167GRCh37Chr 5, 176709500: 176709500
88NSD1NM_022455.4(NSD1): c.5938G> T (p.Glu1980Ter)single nucleotide variantPathogenicrs587784168GRCh37Chr 5, 176709511: 176709511
89NSD1NM_022455.4(NSD1): c.5951G> A (p.Arg1984Gln)single nucleotide variantPathogenicrs587784169GRCh37Chr 5, 176709524: 176709524
90NSD1NM_022455.4(NSD1): c.5965C> T (p.Gln1989Ter)single nucleotide variantPathogenicrs587784170GRCh37Chr 5, 176709538: 176709538
91NSD1NM_022455.4(NSD1): c.5989T> C (p.Tyr1997His)single nucleotide variantPathogenicrs587784171GRCh37Chr 5, 176709562: 176709562
92NSD1NM_022455.4(NSD1): c.6013C> T (p.Arg2005Ter)single nucleotide variantPathogenicrs587784173GRCh37Chr 5, 176710791: 176710791
93NSD1NM_022455.4(NSD1): c.6014G> A (p.Arg2005Gln)single nucleotide variantPathogenicrs587784174GRCh37Chr 5, 176710792: 176710792
94NSD1NM_022455.4(NSD1): c.6043T> C (p.Tyr2015His)single nucleotide variantLikely pathogenicrs587784175GRCh37Chr 5, 176710821: 176710821
95NSD1NM_022455.4(NSD1): c.6049C> T (p.Arg2017Trp)single nucleotide variantPathogenicrs587784176GRCh37Chr 5, 176710827: 176710827
96NSD1NM_022455.4(NSD1): c.6050G> A (p.Arg2017Gln)single nucleotide variantPathogenicrs587784177GRCh37Chr 5, 176710828: 176710828
97NSD1NM_022455.4(NSD1): c.6059A> G (p.Asn2020Ser)single nucleotide variantPathogenicrs587784178GRCh37Chr 5, 176710837: 176710837
98NSD1NM_022455.4(NSD1): c.6070C> T (p.Gln2024Ter)single nucleotide variantPathogenicrs587784179GRCh37Chr 5, 176710848: 176710848
99NSD1NM_022455.4(NSD1): c.6080G> C (p.Cys2027Ser)single nucleotide variantLikely pathogenicrs587784180GRCh37Chr 5, 176710858: 176710858
100NSD1NM_022455.4(NSD1): c.6086C> T (p.Thr2029Ile)single nucleotide variantLikely pathogenicrs587784181GRCh37Chr 5, 176710864: 176710864
101NSD1NM_022455.4(NSD1): c.6157G> T (p.Glu2053Ter)single nucleotide variantPathogenicrs587784183GRCh37Chr 5, 176715825: 176715825
102NSD1NM_022455.4(NSD1): c.6165delC (p.Phe2056Serfs)deletionPathogenicrs587784184GRCh37Chr 5, 176715833: 176715833
103NSD1NM_022455.4(NSD1): c.6258+1G> Asingle nucleotide variantPathogenicrs587784185GRCh37Chr 5, 176715927: 176715927
104NSD1NM_022455.4(NSD1): c.6291delG (p.Lys2098Asnfs)deletionPathogenicrs587784186GRCh37Chr 5, 176718987: 176718987
105NSD1NM_022455.4(NSD1): c.6307C> T (p.Gln2103Ter)single nucleotide variantPathogenicrs587784187GRCh37Chr 5, 176719003: 176719003
106NSD1NM_022455.4(NSD1): c.6310C> T (p.Gln2104Ter)single nucleotide variantPathogenicrs587784188GRCh37Chr 5, 176719006: 176719006
107NSD1NM_022455.4(NSD1): c.6311_6312delAG (p.Gln2104Argfs)deletionPathogenicrs587784189GRCh37Chr 5, 176719007: 176719008
108NSD1NM_022455.4(NSD1): c.6349C> T (p.Arg2117Ter)single nucleotide variantPathogenicrs587784190GRCh37Chr 5, 176719045: 176719045
109NSD1NM_022455.4(NSD1): c.6356A> G (p.Asp2119Gly)single nucleotide variantPathogenicrs587784191GRCh37Chr 5, 176719052: 176719052
110NSD1NM_022455.4(NSD1): c.6366delT (p.Phe2122Leufs)deletionPathogenicrs587784192GRCh37Chr 5, 176719062: 176719062
111NSD1NM_022455.4(NSD1): c.6377A> T (p.Asp2126Val)single nucleotide variantPathogenicrs587784193GRCh37Chr 5, 176719073: 176719073
112NSD1NM_022455.4(NSD1): c.6413G> A (p.Cys2138Tyr)single nucleotide variantLikely pathogenicrs587784195GRCh37Chr 5, 176719109: 176719109
113NSD1NM_022455.4(NSD1): c.6418A> G (p.Lys2140Glu)single nucleotide variantLikely pathogenicrs587784196GRCh37Chr 5, 176719114: 176719114
114NSD1NM_022455.4(NSD1): c.6421delG (p.Val2141Phefs)deletionPathogenicrs587784197GRCh37Chr 5, 176719117: 176719117
115NSD1NM_022455.4(NSD1): c.6431delC (p.Ala2144Glufs)deletionPathogenicrs587784198GRCh37Chr 5, 176719127: 176719127
116NSD1NM_022455.4(NSD1): c.6454C> T (p.Arg2152Ter)single nucleotide variantPathogenicrs587784199GRCh37Chr 5, 176719150: 176719150
117NSD1NM_022455.4(NSD1): c.6455G> A (p.Arg2152Gln)single nucleotide variantPathogenicrs587784200GRCh37Chr 5, 176719151: 176719151
118NSD1NM_022455.4(NSD1): c.6472G> T (p.Glu2158Ter)single nucleotide variantPathogenicrs587784201GRCh37Chr 5, 176720841: 176720841
119NSD1NM_022455.4(NSD1): c.6476G> A (p.Cys2159Tyr)single nucleotide variantPathogenicrs587784202GRCh37Chr 5, 176720845: 176720845
120NSD1NM_022455.4(NSD1): c.6485A> C (p.His2162Pro)single nucleotide variantLikely pathogenicrs587784204GRCh37Chr 5, 176720854: 176720854
121NSD1NM_022455.4(NSD1): c.6500G> A (p.Cys2167Tyr)single nucleotide variantLikely pathogenicrs587784205GRCh37Chr 5, 176720869: 176720869
122NSD1NM_022455.4(NSD1): c.6521_6523delTCT (p.Phe2174del)deletionPathogenicrs587784206GRCh37Chr 5, 176720890: 176720892
123NSD1NM_022455.4(NSD1): c.6539_6557del19 (p.Ser2180Ilefs)deletionPathogenicrs587784207GRCh37Chr 5, 176720908: 176720926
124NSD1NM_022455.4(NSD1): c.6557A> G (p.His2186Arg)single nucleotide variantLikely pathogenicrs587784208GRCh37Chr 5, 176720926: 176720926
125NSD1NM_022455.4(NSD1): c.6559C> T (p.Arg2187Ter)single nucleotide variantPathogenicrs587784209GRCh37Chr 5, 176720928: 176720928
126NSD1NM_022455.4(NSD1): c.6604T> A (p.Cys2202Ser)single nucleotide variantPathogenicrs587784210GRCh37Chr 5, 176720973: 176720973
127NSD1NM_022455.4(NSD1): c.6630_6644delCAATCCTCTGGAACC (p.Asn2211_Pro2215del)deletionLikely pathogenicrs587784211GRCh37Chr 5, 176720999: 176721013
128NSD1NM_022455.4(NSD1): c.6656G> A (p.Arg2219His)single nucleotide variantPathogenicrs587784214GRCh37Chr 5, 176721025: 176721025
129NSD1NM_022455.4(NSD1): c.7939_7940delCA (p.Gln2647Valfs)deletionPathogenicrs587784219GRCh37Chr 5, 176722308: 176722309
130NSD1NM_022455.4(NSD1): c.8036delC (p.Pro2679Glnfs)deletionPathogenicrs587784220GRCh37Chr 5, 176722405: 176722405
131NSD1NM_022455.4(NSD1): c.8043delT (p.Asn2682Thrfs)deletionPathogenicrs587784221GRCh37Chr 5, 176722412: 176722412
132NSD1NM_022455.4(NSD1): c.5332C> T (p.Arg1778Ter)single nucleotide variantPathogenicrs794727176GRCh37Chr 5, 176696631: 176696631
133NSD1NM_022455.4(NSD1): c.4217_4220delGAAA (p.Arg1406Asnfs)deletionPathogenicrs794727930GRCh37Chr 5, 176666781: 176666784
134NSD1NM_022455.4(NSD1): c.1742delA (p.Glu581Aspfs)deletionPathogenicrs794729232GRCh38Chr 5, 177210141: 177210141
135NSD1NM_022455.4(NSD1): c.5950C> T (p.Arg1984Ter)single nucleotide variantPathogenicrs797045057GRCh37Chr 5, 176709523: 176709523
136NSD1NM_022455.4(NSD1): c.7966C> T (p.Gln2656Ter)single nucleotide variantPathogenicrs797045058GRCh37Chr 5, 176722335: 176722335
137NSD1NM_022455.4(NSD1): c.(?_-138)_(7458_?)deldeletionPathogenic
138NSD1NM_022455.4(NSD1): c.1264dupG (p.Glu422Glyfs)duplicationPathogenicrs797045804GRCh37Chr 5, 176636664: 176636664
139NSD1NM_022455.4(NSD1): c.1802dupA (p.Cys602Valfs)duplicationPathogenicrs797045805GRCh38Chr 5, 177210201: 177210201
140NSD1NM_022455.4(NSD1): c.2167dupA (p.Thr723Asnfs)duplicationPathogenicrs797045807GRCh37Chr 5, 176637567: 176637567
141NSD1NM_022455.4(NSD1): c.2190_2191delCTinsG (p.Ser731Leufs)indelPathogenicrs797045808GRCh38Chr 5, 177210589: 177210590
142NSD1NM_022455.4(NSD1): c.2859dupT (p.Lys954Terfs)duplicationPathogenicrs797045809GRCh37Chr 5, 176638259: 176638259
143NSD1NM_022455.4(NSD1): c.3146dupA (p.Thr1050Aspfs)duplicationPathogenicrs797045810GRCh38Chr 5, 177211545: 177211545
144NSD1NM_022455.4(NSD1): c.3259_3265delAAAGAGG (p.Lys1087Ilefs)deletionPathogenicrs797045811GRCh38Chr 5, 177211658: 177211664
145NSD1NM_022455.4(NSD1): c.3316dupT (p.Ser1106Phefs)duplicationPathogenicrs797045812GRCh38Chr 5, 177211715: 177211715
146NSD1NM_022455.4(NSD1): c.3549dupT (p.Glu1184Terfs)duplicationPathogenicrs797045813GRCh38Chr 5, 177211948: 177211948
147NSD1NM_022455.4(NSD1): c.3578dupG (p.Ser1193Argfs)duplicationPathogenicrs797045814GRCh37Chr 5, 176638978: 176638978
148NSD1NM_022455.4(NSD1): c.3939dupA (p.Glu1314Argfs)duplicationPathogenicrs797045815GRCh37Chr 5, 176665255: 176665255
149NSD1NM_022455.4(NSD1): c.4020delA (p.Glu1341Serfs)deletionPathogenicrs797045816GRCh38Chr 5, 177238335: 177238335
150NSD1NM_022455.4(NSD1): c.4282dupG (p.Asp1428Glyfs)duplicationPathogenicrs797045817GRCh38Chr 5, 177239845: 177239845
151NSD1NM_022455.4(NSD1): c.4301dupA (p.Cys1435Valfs)duplicationPathogenicrs797045818GRCh38Chr 5, 177239864: 177239864
152NSD1NM_022455.4(NSD1): c.4479_4488dupAGAGATTCCA (p.Gly1497Argfs)duplicationPathogenicrs797045819GRCh38Chr 5, 177246778: 177246787
153NSD1NM_022455.4(NSD1): c.4732dupA (p.Arg1578Lysfs)duplicationPathogenicrs797045820GRCh38Chr 5, 177251820: 177251820
154NSD1NM_022455.4(NSD1): c.4882_4883insAA (p.Met1628Lysfs)insertionPathogenicrs797045821GRCh38Chr 5, 177257067: 177257068
155NSD1NM_022455.4(NSD1): c.5408_5411delACTAins9indelPathogenicrs797045822GRCh38Chr 5, 177269706: 177269709
156NSD1NM_022455.4(NSD1): c.5407_5410dupGACT (p.Tyr1804Terfs)duplicationPathogenicrs797045823GRCh37Chr 5, 176696706: 176696709
157NSD1NM_022455.4(NSD1): c.5790dupC (p.Cys1931Leufs)duplicationPathogenicrs797045824GRCh38Chr 5, 177280732: 177280732
158NSD1NM_022455.4(NSD1): c.5990A> G (p.Tyr1997Cys)single nucleotide variantPathogenicrs797045825GRCh38Chr 5, 177282562: 177282562
159NSD1NM_022455.4(NSD1): c.6094_6095dupTG (p.Trp2032Cysfs)duplicationPathogenicrs797045826GRCh37Chr 5, 176710872: 176710873
160NSD1NM_022455.4(NSD1): c.6112dupA (p.Thr2038Asnfs)duplicationPathogenicrs797045827GRCh38Chr 5, 177283889: 177283889
161NSD1NM_022455.4(NSD1): c.6218dupG (p.Ala2074Serfs)duplicationPathogenicrs797045828GRCh38Chr 5, 177288885: 177288885
162NSD1NM_022455.4(NSD1): c.6290dupA (p.Lys2098Glufs)duplicationPathogenicrs797045829GRCh38Chr 5, 177291985: 177291985
163NSD1NM_022455.4(NSD1): c.6307_6308insTGTGC (p.Gln2103Leufs)insertionPathogenicrs797045830GRCh38Chr 5, 177292002: 177292003
164NSD1NM_022455.4(NSD1): c.6344dupA (p.Glu2116Glyfs)duplicationPathogenicrs797045831GRCh38Chr 5, 177292039: 177292039
165NSD1NM_022455.4(NSD1): c.6459_6463+5deldeletionPathogenicrs797045832GRCh38Chr 5, 177292154: 177292163
166NSD1NM_022455.4(NSD1): c.6541_6543dupTCC (p.Ser2181_Phe2182insSer)duplicationLikely pathogenicrs797045833GRCh37Chr 5, 176720910: 176720912
167NSD1NM_022455.4(NSD1): c.7783A> T (p.Lys2595Ter)single nucleotide variantPathogenicrs797045834GRCh38Chr 5, 177295151: 177295151
168NSD1NM_022455.4(NSD1): c.2350C> T (p.Gln784Ter)single nucleotide variantLikely pathogenicrs374740802GRCh38Chr 5, 177210749: 177210749
169NSD1NM_022455.4(NSD1): c.5304-1G> Csingle nucleotide variantLikely pathogenicGRCh37Chr 5, 176696602: 176696602
170NSD1NSD1, 1.9-MB DELdeletionPathogenic
171NSD1NM_022455.4(NSD1): c.1310C> G (p.Ser437Ter)single nucleotide variantPathogenicrs121908067GRCh37Chr 5, 176636710: 176636710
172NSD1NSD1, 1-BP DEL, 3536AdeletionPathogenic
173NSD1NSD1, 1-BP INS, 5998TinsertionPathogenic
174NSD1NSD1, IVS20DS, G-A, +1single nucleotide variantPathogenic
175NSD1NM_022455.4(NSD1): c.6429C> G (p.His2143Gln)single nucleotide variantPathogenicrs121908068GRCh37Chr 5, 176719125: 176719125
176NSD1NM_022455.4(NSD1): c.6548G> C (p.Cys2183Ser)single nucleotide variantPathogenicrs121908069GRCh37Chr 5, 176720917: 176720917
177NSD1NSD1, 1-BP INS, 6450CinsertionPathogenic
178NSD1NSD1, 1-BP DEL, 896CdeletionPathogenic
179NSD1NM_022455.4(NSD1): c.3958C> T (p.Arg1320Ter)single nucleotide variantPathogenicrs121908070GRCh37Chr 5, 176665274: 176665274
180NSD1NM_022455.4(NSD1): c.6605G> A (p.Cys2202Tyr)single nucleotide variantPathogenicrs121908071GRCh37Chr 5, 176720974: 176720974
181NSD1NM_022455.4(NSD1): c.2349delA (p.Lys783Asnfs)deletionPathogenicrs398124374GRCh37Chr 5, 176637749: 176637749
182NSD1NM_022455.4(NSD1): c.4892A> G (p.Lys1631Arg)single nucleotide variantLikely pathogenicrs201857437GRCh37Chr 5, 176684078: 176684078
183NSD1NM_022455.4(NSD1): c.5279_5282delTCTG (p.Val1760Glyfs)deletionPathogenicrs398124379GRCh37Chr 5, 176694695: 176694698
184NSD1NM_022455.4(NSD1): c.6463+1G> Asingle nucleotide variantPathogenicrs398124381GRCh37Chr 5, 176719160: 176719160
185NSD1NM_022455.4(NSD1): c.6538_6539insC (p.Ser2180Thrfs)insertionPathogenicrs398124383GRCh37Chr 5, 176720907: 176720908

Expression for genes affiliated with Sotos Syndrome 1

About this section
Search GEO for disease gene expression data for Sotos Syndrome 1.

Pathways for genes affiliated with Sotos Syndrome 1

About this section

Pathways related to Sotos Syndrome 1 according to GeneCards Suite gene sharing:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
18.9NSD1, SETD2, WHSC1, WHSC1L1

GO Terms for genes affiliated with Sotos Syndrome 1

About this section

Cellular components related to Sotos Syndrome 1 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1chromosomeGO:00056948.9NSD1, SETD2, WHSC1, WHSC1L1

Biological processes related to Sotos Syndrome 1 according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1histone H4-K20 methylationGO:003477010.5NSD1, WHSC1
2glycosaminoglycan biosynthetic processGO:000602410.2B4GALT7, GPC3
3histone H3-K36 methylationGO:001045210.2NSD1, SETD2, WHSC1
4embryonic organ developmentGO:004856810.2SETD2, ZFP36L1
5histone methylationGO:00165719.8NSD1, WHSC1L1
6negative regulation of cell proliferationGO:00082859.2DIS3L2, GPC3, IGFBP3, NRK
7chromatin organizationGO:00063258.9NSD1, SETD2, WHSC1, WHSC1L1

Molecular functions related to Sotos Syndrome 1 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1histone methyltransferase activity (H4-K20 specific)GO:004279910.1NSD1, WHSC1
2histone methyltransferase activity (H3-K36 specific)GO:004697510.0NSD1, SETD2
3histone-lysine N-methyltransferase activityGO:00180248.6NSD1, SETD2, WHSC1, WHSC1L1

Sources for Sotos Syndrome 1

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet